ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Clinical trial NCT04645069 · COMPLETED

Trial details

NCT number: NCT04645069
Sponsor: Adagene Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2021-03-15
Primary completion: 2024-01-29
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.